Xiong Tian-Yuan, Zheng Ming-Xia, Wei Xin, Li Yi-Jian, Liao Yan-Biao, Zhao Zhen-Gang, Xu Yuan-Ning, Tang Hong, Feng Yuan, Chen Mao
West China Hospital, Sichuan University.
Cardiol J. 2017;24(4):350-357. doi: 10.5603/CJ.a2017.0020. Epub 2017 Mar 1.
To investigate the individual sequential hemodynamic changes after transcatheter aortic valve implantation (TAVI), especially for patients with bicuspid aortic valve (BAV), in comparison with tricuspid aortic valve (TAV).
The study population comprised 85 patients with severe aortic stenosis who underwent TAVI for BAV (n = 49) or TAV (n = 36) with at least two serial echocardiographic follow-ups. Doppler echocardiography was scheduled to be performed at discharge and 1, 3, 6 months and 1 year after the procedure. D peak transvalvular velocities and D mean transvalvular gradients were calculated as the difference at follow-up time points and discharge. Paravalvular leak (PVL) was assessed as another indicator for prosthesis performance.
Comparisons between patients with BAV and TAV revealed similar gradient performances (1.00 [-2.00, 2.00] vs. 1.00 [-0.25, 5.00] mm Hg, p = 0.57 at 1 month; -0.71 ± 7.52 vs. 1.55 ± 3.97 mm Hg, p = 0.21 at 3 months; 0.96 ± 7.81 vs. 1.53 ± 5.85 mm Hg, p = 0.79 at 6 months; 1.00 [-0.50, 2.25] vs. 3.00 [-0.50, 7.50] mm Hg, p = 0.07 at 1 year). Moreover, the incidence of ≥ mild PVL was not significantly different in patients with BAV and TAV during follow-up (34.88% vs. 19.35%, p = 0.14 at 1 month; 45.83% vs. 27.27%, p = 0.19 at 3 months; 30.00% vs. 23.53%, p = 0.89 at 6 months; 30.00% vs. 17.65%, p = 0.56 at 1 year).
TAVI is effective and applicable in BAV anatomy with sustained and acceptable mid- -term prosthesis hemodynamic performance. (Cardiol J 2017; 24, 4: 350-357).
研究经导管主动脉瓣植入术(TAVI)后个体序贯血流动力学变化,尤其是二叶式主动脉瓣(BAV)患者,并与三叶式主动脉瓣(TAV)患者进行比较。
研究人群包括85例重度主动脉瓣狭窄患者,这些患者因BAV(n = 49)或TAV(n = 36)接受了TAVI,且至少有两次连续的超声心动图随访。计划在出院时以及术后1、3、6个月和1年进行多普勒超声心动图检查。计算随访时间点与出院时D峰值跨瓣速度和D平均跨瓣压差的差值。评估瓣周漏(PVL)作为人工瓣膜性能的另一指标。
BAV患者和TAV患者之间的比较显示,梯度表现相似(1个月时为1.00 [-2.00, 2.00] vs. 1.00 [-0.25, 5.00] mmHg,p = 0.57;3个月时为-0.71 ± 7.52 vs. 1.55 ± 3.97 mmHg,p = 0.21;6个月时为0.96 ± 7.81 vs. 1.53 ± 5.85 mmHg,p = 0.79;1年时为1.00 [-0.50, 2.25] vs. 3.00 [-0.50, 7.50] mmHg,p = 0.07)。此外,随访期间BAV患者和TAV患者中≥轻度PVL的发生率无显著差异(1个月时为34.88% vs. 19.35%,p = 0.14;3个月时为45.83% vs. 27.27%,p = 0.19;6个月时为30.00% vs. 23.53%,p = 0.89;1年时为30.00% vs. 17.65%,p = 0.56)。
TAVI在BAV解剖结构中有效且适用,人工瓣膜中期血流动力学性能持续且可接受)。(《心脏病学杂志》2017年;24卷,第4期:350 - 357页)